National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 48182 [2024-12265]
Download as PDF
48182
Federal Register / Vol. 89, No. 109 / Wednesday, June 5, 2024 / Notices
20892, (301) 594–7735, pandharej2@
csr.nih.gov.
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review Group;
Hepatobiliary Pathophysiology Study
Section.
Date: June 27–28, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852 (In
Person).
Contact Person: Jianxin Hu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2156,
Bethesda, MD 20892, 301–827–4417,
jianxinh@csr.nih.gov.
Name of Committee: Infectious Diseases
and Immunology A Integrated Review Group;
Cellular and Molecular Immunology—B
Study Section.
Date: June 27–28, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Liying Guo, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4198,
MSC 7812, Bethesda, MD 20892, (301) 827–
7728, lguo@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 30, 2024.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–12263 Filed 6–4–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications or
contract proposals discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
VerDate Sep<11>2014
16:50 Jun 04, 2024
Jkt 262001
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
K99/R00 MOSAIC-Maximizing Opportunities
for Scientific and Academic Independent
Careers.
Date: July 8, 2024.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health
Rockledge I 6705 Rockledge Drive Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Nawazish Ali Naqvi,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung and Blood Institute, National Institutes
of Health, 6705 Rockledge Drive, Room 208–
Y, Bethesda, MD 20892, (301) 827–7911,
nawazish.naqvi@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Multi-Ethnic Study in Atherosclerosis
(MESA).
Date: July 11, 2024.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Sun Saret, Ph.D., Scientific
Review Officer, Office of Scientific Review/
DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705
Rockledge Drive, Room 208–S Bethesda, MD
20892, (301) 435–0270 sun.saret@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Short Term Training Program.
Date: July 15, 2024.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Michael P. Reilly, Ph.D.
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 208–Z
Bethesda, MD 20892, (301) 827–7975
reillymp@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Physician Scientist Transition to
Independence in Blood Science Research
(R00—Clinical Trial Optional).
Date: July 17, 2024.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Nawazish Ali Naqvi,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung and Blood Institute, National Institutes
of Health, 6705 Rockledge Drive, Room 208–
Y Bethesda, MD 20892, (301) 827–7911
nawazish.naqvi@nih.gov.
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Catalyze Product Definition for Small
Molecules and Biologics.
Date: July 18, 2024.
Time: 10:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Rajiv Kumar, Ph.D.,
Branch Chief, Blood and Vascular Branch
Office of Scientific Review/DERA, National
Heart, Lung, and Blood Institute, National
Institutes of Health, 6705 Rockledge Drive,
208–W Bethesda, MD 20892, 301–827–4612
rajiv.kumar@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
R35 OIA Review.
Date: July 24–25, 2024.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Bethesda, 7301
Waverly Street, Bethesda, MD 20814 (Hybrid
Meeting).
Contact Person: Kristen Page, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Suite 209–B Bethesda,
MD 20892, (301) 827–7953 kristen.page@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: May 30, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–12265 Filed 6–4–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request; Withdrawal
In compliance with section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
E:\FR\FM\05JNN1.SGM
05JNN1
Agencies
[Federal Register Volume 89, Number 109 (Wednesday, June 5, 2024)]
[Notices]
[Page 48182]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-12265]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications or contract proposals
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; K99/R00 MOSAIC-Maximizing Opportunities for
Scientific and Academic Independent Careers.
Date: July 8, 2024.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health Rockledge I 6705 Rockledge
Drive Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Nawazish Ali Naqvi, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 208-Y, Bethesda, MD 20892, (301) 827-7911,
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Multi-Ethnic Study in Atherosclerosis
(MESA).
Date: July 11, 2024.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sun Saret, Ph.D., Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705 Rockledge Drive, Room
208-S Bethesda, MD 20892, (301) 435-0270 [email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Short Term Training Program.
Date: July 15, 2024.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael P. Reilly, Ph.D. Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 208-Z Bethesda, MD 20892, (301) 827-7975
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Physician Scientist Transition to
Independence in Blood Science Research (R00--Clinical Trial
Optional).
Date: July 17, 2024.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Nawazish Ali Naqvi, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 208-Y Bethesda, MD 20892, (301) 827-7911
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Catalyze Product Definition for Small
Molecules and Biologics.
Date: July 18, 2024.
Time: 10:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Rajiv Kumar, Ph.D., Branch Chief, Blood and
Vascular Branch Office of Scientific Review/DERA, National Heart,
Lung, and Blood Institute, National Institutes of Health, 6705
Rockledge Drive, 208-W Bethesda, MD 20892, 301-827-4612
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; R35 OIA Review.
Date: July 24-25, 2024.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Garden Inn Bethesda, 7301 Waverly Street,
Bethesda, MD 20814 (Hybrid Meeting).
Contact Person: Kristen Page, Ph.D., Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705 Rockledge Drive,
Suite 209-B Bethesda, MD 20892, (301) 827-7953 [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: May 30, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-12265 Filed 6-4-24; 8:45 am]
BILLING CODE 4140-01-P